Menu

Impact Events

More
Date Lead Company Event Type Approval Change Approval Likelihood
9/29/23 AbbVie (ABBV) Venclexta for Multiple Myeloma (MM) Subscribers Only Subscribers Only Subscribers Only
9/27/23 BrainStorm (BCLI) NurOwn for Amyotrophic Lateral Sclerosis (ALS) Subscribers Only Subscribers Only Subscribers Only
9/25/23 BrainStorm (BCLI) NurOwn for Amyotrophic Lateral Sclerosis (ALS) Subscribers Only Subscribers Only Subscribers Only
9/23/23 4SC (VSC) Resminostat for Cutaneous T-Cell Lymphoma (CTCL) - NHL Subscribers Only Subscribers Only Subscribers Only
9/22/23 Astellas Pharma (4503:JP) Padcev for Bladder Cancer Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

More
Expected Date Range Lead Company Drug Expected Catalyst
09/30/23 Subscribers Only Subscribers Only Trial Announcement - Trial Completion
09/30/23 Subscribers Only Subscribers Only Trial Announcement - Initiation
09/30/23 Subscribers Only Subscribers Only Trial Announcement - Initiation (Emerging Markets)
09/30/23 Subscribers Only Subscribers Only Regulatory - IND/CTA Filing
09/30/23 Subscribers Only Subscribers Only Trial Announcement - Patient Enrollment Completed
Back to the top Back to the top